Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary

References

• Alsaied, T., Marino, B. S., Esbensen, A. J., Anixt, J. S., Epstein, J. N. and Cnota, J. F. 2016. Does congenital heart disease affect neurodevelopmental outcomes in children with Down syndrome? Congenital Heart Disease, 11, 26–33.10.1111/chd.2016.11.issue-1
   PubMed Web of Science ®Google Scholar
• Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D. and Alzheimer’s Disease Neuroimaging Initiative Investigators. 2014. Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of Neurology, 75, 563–573.10.1002/ana.v75.4
   PubMed Web of Science ®Google Scholar
• Alzheimer Society of Canada. 2016. About dementia. Risk factors. Available at: <http://www.alzheimer.ca/en/About-dementia/Alzheimer-s-disease/Risk-factors>
   Google Scholar
• Anand, S. S., Hawkes, C., de Souza, R. J., Mente, A., Dehghan, M., Nugent, R., Zulyniak, M. A., Weis, T., Bernstein, A. M., Krauss, R. M., Kromhout, D., Jenkins, D. J., Malik, V., Martinez-Gonzalez, M. A., Mozaffarian, D., Yusuf, S., Willett, W. C. and Popkin, B. M. 2015. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. Journal of the American College of Cardiology, 66, 1590–1614.10.1016/j.jacc.2015.07.050
   PubMed Web of Science ®Google Scholar
• Attems, J. and Jellinger, K. A. 2014. The overlap between vascular disease and Alzheimer’s disease — lessons from pathology. BMC Medicine, 12, 206. doi:10.1186/s12916-014-0206-2.
   PubMed Web of Science ®Google Scholar
• Austin, B. P., Nair, V. A., Meier, T. B., Xu, G., Rowley, H. A., Carlsson, C. M., Johnson, S. C. and Prabhakaran, V. 2011. Effects of hypoperfusion in Alzheimer’s disease. Journal of Alzheimer’s Disease, 26, 123–133.
   PubMed Web of Science ®Google Scholar
• Aversa, T., Valenzise, M., Salerno, M., Corrias, A., Iughetti, L., Radetti, G., De Luca, F. and Wasniewska, M. 2015. Metamorphic thyroid autoimmunity in Down syndrome: from Hashimoto’s thyroiditis to Graves’ disease and beyond. Italian Journal of Pediatrics, 41, 87. doi: 10.1186/s13052-015-0197-4.
   PubMed Web of Science ®Google Scholar
• Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D. and Jones, E. 2011. Alzheimer’s disease. The Lancet, 377, 1019–1031.10.1016/S0140-6736(10)61349-9
   PubMed Web of Science ®Google Scholar
• Ballard, C., Mobley, W., Hardy, J., Williams, G. and Corbett, A. 2016. Dementia in Down’s syndrome. The Lancet Neurology, 15, 622–636.10.1016/S1474-4422(16)00063-6
   PubMed Web of Science ®Google Scholar
• Barnes, D. E., Kaup, A., Kirby, K. A., Byers, A. L., Diaz-Arrastia, R. and Yaffe, K. 2014. Traumatic brain injury and risk of dementia in older veterans. Neurology, 83, 312–319.10.1212/WNL.0000000000000616
   PubMed Web of Science ®Google Scholar
• Bennett, S. and Thomas, A. J. 2014. Depression and dementia: cause, consequence or coincidence? Maturitas, 79, 184–190.10.1016/j.maturitas.2014.05.009
   PubMed Web of Science ®Google Scholar
• Bergström, S., Carr, H., Petersson, G., Stephansson, O., Bonamy, A. K., Dahlström, A., Halvorsen, C. P. and Johansson, S. 2016. Trends in congenital heart defects in infants with Down syndrome. Pediatrics, 138. pii: e20160123
   PubMed Web of Science ®Google Scholar
• Bhattacharjee, S., Zhao, Y., Hill, J. M., Percy, M. E. and Lukiw, W. J. 2014. Aluminum and its potential contribution to Alzheimer’s disease (AD). Frontiers in Aging Neuroscience, 6, 62. doi: 10.3389/fnagi.2014.00062.
   PubMed Web of Science ®Google Scholar
• Bird, T. D. 2008. Genetic aspects of Alzheimer disease. Genetics in Medicine, 10, 231–239.10.1097/GIM.0b013e31816b64dc
   PubMed Web of Science ®Google Scholar
• Brodtmann, A. 2009. Hashimoto encephalopathy and Down syndrome. Archives of Neurology, 66, 663–666.
   PubMedGoogle Scholar
• Cannon, J. A., McMurray, J. J. V. and Quinn, T. J. 2015. ‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure. Alzheimer’s Research & Therapy, 7, 22. doi:10.1186/s13195-015-0106-5.
   PubMed Web of Science ®Google Scholar
• Cebeci, A. N., Güven, A. and Yıldız, M. 2013. Profile of hypothyroidism in Down’s syndrome. Journal of Clinical Research in Pediatric Endocrinology, 5, 116–120.10.4274/Jcrpe
   PubMed Web of Science ®Google Scholar
• Cermakova, P., Lund, L. H., Fereshtehnejad, S. M., Johnell, K., Winblad, B., Dahlström, U., Eriksdotter, M. and Religa, D. 2015. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. European Journal of Heart Failure, 17, 612–619.10.1002/ejhf.2015.17.issue-6
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin, M.-C., Partita, M., Legrain, S., Perez-Tur, J., Brousseau, T., Evans, A., Berr, C., Vldal, O., Roques, P., Gouriet, V., Fruchart, J.-C., Delacourte, A., Rossor, M. and Amouyel, P. 1994. Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: analysis of the 19q13.2 chromosomal region. Human Molecular Genetics, 3, 569–574.10.1093/hmg/3.4.569
   PubMed Web of Science ®Google Scholar
• Coleman, M. 1994. Thyroid dysfunction in Down syndrome: a review. DSEducation Online. Available at: <https://www.down-syndrome.org/reviews/40/>
   Google Scholar
• Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Jr, Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180–184.10.1038/ng0694-180
   PubMed Web of Science ®Google Scholar
• Dalton, A. J., Mehta, P. D., Fedor, B. L. and Patti, P. J. 1999. Cognitive changes in memory precede those in praxis in aging persons with Down syndrome. Journal of Intellectual & Developmental Disability, 24, 169–187.10.1080/13668259900033961
   Web of Science ®Google Scholar
• de la Torre, J. C. 2012. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovascular Psychiatry and Neurology, 2012, 15 pages, Article ID 367516.
   Google Scholar
• Eichner, J. E., Dunn, S. T., Perveen, G., Thompson, D. M., Stewart, K. E. and Stroehla, B. C. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. American Journal of Epidemiology, 155, 487–495.10.1093/aje/155.6.487
   PubMed Web of Science ®Google Scholar
• Etgen, T. 2015. Kidney disease as a determinant of cognitive decline and dementia. Alzheimer’s Research & Therapy, 7, 29. doi:10.1186/s13195-015-0115-4.
   PubMed Web of Science ®Google Scholar
• Ewbank, D. C. 2004. The APOE gene and differences in life expectancy in Europe. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 59, B16–B20.10.1093/gerona/59.1.B16
   PubMed Web of Science ®Google Scholar
• Fazio, S., Palmieri, E. A., Lombardi, G. and Biondi, B. 2004. Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research, 59, 31–50.10.1210/rp.59.1.31
   PubMedGoogle Scholar
• Femminella, G. D., Ferrara, N. and Rengo, G. 2015. The emerging role of microRNAs in Alzheimer’s disease. Frontiers in Physiology, 6, 40. doi: 10.3389/fphys.2015.00040
   PubMed Web of Science ®Google Scholar
• Fiest, K. M., Roberts, J. I., Maxwell, C. J., Hogan, D. B., Smith, E. E., Frolkis, A., Cohen, A., Kirk, A., Pearson, D., Pringsheim, T., Venegas-Torres, A. and Jetté, N. 2016. The prevalence and incidence of dementia due to Alzheimer’s disease: a systematic review and meta-analysis. Canadian Journal of Neurological Sciences, 43, S51–S82.10.1017/cjn.2016.36
   PubMed Web of Science ®Google Scholar
• Freeman, S. B., Taft, L. F., Dooley, K. J., Allran, K., Sherman, S. L., Hassold, T. J., Khoury, M. J. and Saker, D. M. 1998. Population-based study of congenital heart defects in Down syndrome. American Journal of Medical Genetics, 80, 213–217.10.1002/(ISSN)1096-8628
   PubMed Web of Science ®Google Scholar
• Gan, E. H. and Pearce, S. H. 2012. Clinical review: the thyroid in mind: cognitive function and low thyrotropin in older people. The Journal of Clinical Endocrinology & Metabolism, 97, 3438–3449.10.1210/jc.2012-2284
   PubMed Web of Science ®Google Scholar
• Goldhaber, S. Z., Rubin, I. L., Brown, W., Robertson, N., Stubblefield, F. and Sloss, L. J. 1986. Valvular heart disease (Aortic regurgitation and mitral valve prolapse) among institutionalized adults with down's syndrome. The American Journal of Cardiology, 57, 278–281.10.1016/0002-9149(86)90905-7
   PubMed Web of Science ®Google Scholar
• GraphPad Software, Inc. 2016. QuickCalcs. Available at: <http://graphpad.com/quickcalcs/contingency1.cfm>
   Google Scholar
• Greenough, M. A., Camakaris, J. and Bush, A. I. 2013. Metal dyshomeostasis and oxidative stress in Alzheimer’s disease. Neurochemistry International, 62, 540–555.10.1016/j.neuint.2012.08.014
   PubMed Web of Science ®Google Scholar
• Hardy, J. and Allsop, D. 1999. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends in Pharmacological Sciences, 12, 383–388.
   Google Scholar
• Head, E., Lott, I. T., Wilcock, D. M. and Lemere, C. A. 2016. Aging in DS and the development of Alzheimer’s disease neuropathology. Current Alzheimer Research, 13, 18–29.
   PubMed Web of Science ®Google Scholar
• Heath, C. A., Mercer, S. W. and Guthrie, B. 2015. Vascular comorbidities in younger people with dementia: a cross-sectional population-based study of 616 245 middle-aged people in Scotland. Journal of Neurology, Neurosurgery, & Psychiatry, 86, 959–964.10.1136/jnnp-2014-309033
   PubMed Web of Science ®Google Scholar
• Herbert, S. and Tulloh, R. M. R. 2015. Treatment of pulmonary hypertension in Down’s syndrome. Journal of Genetic Syndromes and Gene Therapy, 6, 3. doi:10.4172/2157-7412.1000273.
   Google Scholar
• Herrup, K. 2015. The case for rejecting the amyloid cascade hypothesis. Nature Neuroscience, 18, 794–799.10.1038/nn.4017
   PubMed Web of Science ®Google Scholar
• Hill, J. M., Bhattacharjee, S., Pogue, A. I. and Lukiw, W. J. 2014. The gastrointestinal tract microbiome and potential link to Alzheimer’s disease. Frontiers in Neurology, 5, 43. doi:10.3389/fneur.2014.00043.
   PubMed Web of Science ®Google Scholar
• Hill, J. M., Clement, C., Pogue, A. I., Bhattacharjee, S., Zhao, Y. and Lukiw, W. J. 2014. Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Frontiers in Aging Neuroscience, 6, 127. doi:10.3389/fnagi.2014.00127.
   PubMed Web of Science ®Google Scholar
• Houlden, H., Crook, R., Backhovens, H., Prihar, G., Baker, M., Hutton, M., Rossor, M., Martin, J. J., Van Broeckhoven, C. and Hardy, J. 1998. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer’s disease families. American Journal of Medical Genetics, 81, 117–121.10.1002/(ISSN)1096-8628
   PubMed Web of Science ®Google Scholar
• Iqbal, K. and Grundke-Iqbal, I. 2010. Alzheimer’s disease, a multifactorial disorder seeking multitherapies. Alzheimer’s & Dementia, 6, 420–424.10.1016/j.jalz.2010.04.006
   PubMed Web of Science ®Google Scholar
• Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., Del Tredici, K., Field, H., Fulop, T., Grassi, C., Griffin, W. S., Haas J Hudson, A. P., Kamer, A. R., Kell, D. B., Licastro, F., Letenneur, L., Lövheim, H., Mancuso, R., Miklossy, J., Otth, C., Palamara, A. T., Perry, G., Preston, C., Pretorius, E., Strandberg, T., Tabet, N., Taylor-Robinson, S. D. and Whittum-Hudson, J. A. 2016. Microbes and Alzheimer’s disease. Journal of Alzheimer’s Disease, 51, 979–984.10.3233/JAD-160152
   PubMed Web of Science ®Google Scholar
• Janicki, M. P. and Dalton, A. J. 2000. Prevalence of dementia and impact on intellectual disability services. Mental Retardation, 38, 276–288.10.1352/0047-6765(2000)038<0276:PODAIO>2.0.CO;2
   PubMedGoogle Scholar
• Jervis, G. A. 1948. Early senile dementia mongoloid idiocy. American Journal of Psychiatry, 105, 102–106.10.1176/ajp.105.2.102
   PubMed Web of Science ®Google Scholar
• Joosten, M. M., Gansevoort, R. T., Mukamal, K. J., van der Harst, P., Geleijnse, J. M., Feskens, E. J., Navis, G., Bakker, S. J. and PREVEND Study Group. 2013. Urinary and plasma magnesium and risk of ischemic heart disease. American Journal of Clinical Nutrition, 97, 1299–1306.10.3945/ajcn.112.054114
   PubMed Web of Science ®Google Scholar
• Justin, B. N., Turek, M. and Hakim, A. M. 2013. Heart disease as a risk factor for dementia. Clinical Epidemiology, 5, 135–145.
   PubMedGoogle Scholar
• Kamer, A. R., Fortea, J. O., Videla, S., Mayoral, A., Janal, M., Carmona-Iragui, M., Benejam, B., Craig, R. G., Saxena, D., Corby, P., Glodzik, L., Annam, K. R., Robbins, M. and de Leon, M. J. 2016. Periodontal disease’s contribution to Alzheimer’s disease progression in Down syndrome. Alzheimer’s & Dementia, 2, 49–57.
   Google Scholar
• Karran, E. and De Strooper, B. 2016. The amyloid cascade hypothesis: are we poised for success or failure? Journal of Neurochemistry. doi: 10.1111/jnc.13632
   PubMed Web of Science ®Google Scholar
• Kerins, G., Petrovic, K., Bruder, M. B. and Gruman, C. 2008. Medical conditions and medication use in adults with Down syndrome: a descriptive analysis. Down Syndrome Research and Practice, 12, 141–147.10.3104/research
   PubMedGoogle Scholar
• King, P. and Tulloh, R. 2011. Management of pulmonary hypertension and Down syndrome. International Journal of Clinical Practice (174), 8–13.10.1111/ijcp.2011.65.issue-s174
   Google Scholar
• Klein, I. and Danzi, S. 2007. Thyroid disease and the heart. Circulation, 116, 1725–1735. Erratum in: Circulation. 2008 Jan 22;117(3):e18. 10.1161/CIRCULATIONAHA.106.678326
   PubMed Web of Science ®Google Scholar
• Ko, J. M. 2015. Genetic syndromes associated with congenital heart disease. Korean Circulation Journal, 45, 357–361.10.4070/kcj.2015.45.5.357
   PubMed Web of Science ®Google Scholar
• Kolte, D., Vijayaraghavan, K., Khera, S., Sica, D. A. and Frishman, W. H. 2014. Role of magnesium in cardiovascular diseases. Cardiology in Review, 22, 182–192.10.1097/CRD.0000000000000003
   PubMed Web of Science ®Google Scholar
• Kumar, D. K., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E. and Moir, R. D. 2016. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Science Translational Medicine, 8, 340ra72. doi: 10.1126/scitranslmed.aaf1059.
   PubMed Web of Science ®Google Scholar
• Lana-Elola, E., Watson-Scales, S. D., Fisher, E. M. C. and Tybulewicz, V. L. J. 2011. Down syndrome: searching for the genetic culprits. Disease Models & Mechanisms, 4, 586–595.10.1242/dmm.008078
   PubMed Web of Science ®Google Scholar
• Letourneau, A., Santoni, F. A., Bonilla, X., Sailani, M. R., Gonzalez, D., Kind, J., Chevalier, C., Thurman, R., Sandstrom, R. S., Hibaoui, Y., Garieri, M., Popadin, K., Falconnet, E., Gagnebin, M., Gehrig, C., Vannier, A., Guipponi, M., Farinelli, L., Borel, C., Migliavacca, E., Borel, C., Deutsch, S., Feki, A., Stamatoyannopoulos, J. A., Herault, Y., van Steensel, B., Guigo, R. and Antonarakis, S. E. 2014. Domains of genome-wide gene expression dysregulation in Down’s syndrome. Nature, 508, 345–350.10.1038/nature13200
   PubMed Web of Science ®Google Scholar
• Li, Y. Y., Alexandrov, P. N., Pogue, A. I., Zhao, Y., Bhattacharjee, S. and Lukiw, W. J. 2012. miRNA-155 upregulation and complement factor H deficits in Down’s syndrome. NeuroReport, 23, 168–173.10.1097/WNR.0b013e32834f4eb4
   PubMed Web of Science ®Google Scholar
• Littlejohns, T. J., Henley, W. E., Lang, I. A., Annweiler, C., Beauchet, O., Chaves, P. H., Fried, L., Kestenbaum, B. R., Kuller, L. H., Langa, K. M., Lopez, O. L., Kos, K., Soni, M., Llewellyn, D. J. 2014. Vitamin D and the risk of dementia and Alzheimer disease. Neurology, 83, 920–928.10.1212/WNL.0000000000000755
   PubMed Web of Science ®Google Scholar
• Lowry, R. 2016. Fisher exact probability test: 2 × 4. Available at: http://vassarstats.net/fisher2x4.html
   Google Scholar
• Lutz, M. W., Crenshaw, D., Welsh-Bohmer, K. A., Burns, D. K. and Roses, A. D. 2016. New genetic approaches to AD: lessons from APOE-TOMM40 phylogenetics. Current Neurology and Neuroscience Reports, 16, 48. doi:10.1007/s11910-016-0643-8.
   PubMed Web of Science ®Google Scholar
• Mann, D. M., Royston, M. C. and Ravindra, C. R. 1990. Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia. Journal of the Neurological Sciences, 99, 153–164.10.1016/0022-510X(90)90152-D
   PubMed Web of Science ®Google Scholar
• MedCalc. 2016. Odds ratio calculator 16.4.3. Available at: <https://www.medcalc.org/calc/odds_ratio.php>
   Google Scholar
• Mégarbané, A., Ravel, A., Mircher, C., Sturtz, F., Grattau, Y., Rethoré, M. O., Delabar, J. M. and Mobley, W. C. 2009. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genetics in Medicine, 11, 611–616.10.1097/GIM.0b013e3181b2e34c
   PubMed Web of Science ®Google Scholar
• Menotti, A., Puddu, P. E., Maiani, G. and Catasta, G. 2015. Lifestyle behaviour and lifetime incidence of heart diseases. International Journal of Cardiology, 201, 293–299.10.1016/j.ijcard.2015.08.050
   PubMed Web of Science ®Google Scholar
• Merrill, S. J. and Mu, Y. 2015. Thyroid autoimmunity as a window to autoimmunity: an explanation for sex differences in the prevalence of thyroid autoimmunity. Journal of Theoretical Biology, 375, 95–100.10.1016/j.jtbi.2014.12.015
   PubMed Web of Science ®Google Scholar
• Mıhçı, E., Akçurin, G., Eren, E., Kardelen, F., Akçurin, S., Keser, I. and Ertuğ, H. 2010. Evaluation of congenital heart diseases and thyroid abnormalities in children with Down syndrome. Anadolu Kardiyoloji Dergisi [The Anatolian Journal of Cardiology], 10, 440–445.
   PubMedGoogle Scholar
• National Institute on Aging. 2016. Preventing Alzheimer’s disease: what do we know? Available at: <https://www.nia.nih.gov/alzheimers/publication/preventing-alzheimers-disease/risk-factors-alzheimers-disease>
   Google Scholar
• O’Brien, J. T. and Thomas, A. 2015. Vascular dementia. The Lancet, 386, 1698–1706.10.1016/S0140-6736(15)00463-8
   PubMed Web of Science ®Google Scholar
• Online Mendelian Inheritance in Man. 2016. 104760: amyloid beta A4 precursor protein; APP. Available at: <http://www.omim.org/entry/104760?search=amyloid%20precursor%20protein&highlight=amyloid%20precursor%20protein%20proteinaceous>
   Google Scholar
• Osimani, A., Berger, A., Friedman, J., Porat-Katz, B. S. and Abarbanel, J. M. 2005. Neuropsychology of vitamin B₁₂ deficiency in elderly dementia patients and control subjects. Journal of Geriatric Psychiatry and Neurology, 18, 33–38.10.1177/0891988704272308
   PubMed Web of Science ®Google Scholar
• Patel, A., Rees, S. D., Kelly, M. A., Bain, S. C., Barnett, A. H., Thalitaya, D. and Prasher, V. P. 2011. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer’s disease in subjects with Down syndrome. Neuroscience Letters, 487, 144–148.10.1016/j.neulet.2010.10.010
   PubMed Web of Science ®Google Scholar
• Payer, J., Petrovic, T., Lisy, L. and Langer, P. 2012. Hashimoto encephalopathy: a rare intricate syndrome. International Journal of Endocrinology & Metabolism, 10, 506–514.10.5812/ijem
   PubMedGoogle Scholar
• Percy, M. E., Dalton, A. J., Markovic, V. D., Crapper McLachlan, D. R., Gera, E., Hummel, J. T., Rusk, A. C., Somerville, M. J., Andrews, D. F. and Walfish, P. G. 1990. Autoimmune thyroiditis associated with mild “subclinical” hypothyroidism in adults with down syndrome: a comparison of patients with and without manifestations of Alzheimer disease. American Journal of Medical Genetics, 36, 148–154.10.1002/(ISSN)1096-8628
   PubMed Web of Science ®Google Scholar
• Percy, M. E., Kruck, T. P., Pogue, A. I. and Lukiw, W. J. 2011. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer’s disease. Journal of Inorganic Biochemistry, 105, 1505–1512.10.1016/j.jinorgbio.2011.08.001
   PubMed Web of Science ®Google Scholar
• Percy, M. E., Potyomkina, Z., Dalton, A. J., Fedor, B., Mehta, P., Andrews, D. F., Mazzulli, T., Murk, L., Warren, A. C., Wallace, R. A., Chau, H., Jeng, W., Moalem, S., O’Brien, L., Schellenberger, S., Tran, H. and Wu, L. 2003. Relation between apolipoprotein E genotype, hepatitis b virus status, and thyroid status in a sample of older persons with down syndrome. American Journal of Medical Genetics, 120A, 191–198.10.1002/(ISSN)1096-8628
   PubMed Web of Science ®Google Scholar
• Percy, M. and Prasher, V. P. 2006. Thyroid disorders, dementia and Down syndrome. In: Prasher, V. P., ed. Down syndrome and Alzheimer’s disease. Biological correlates. Abingdon: Radcliffe Publishing Ltd. pp.99–140.
   Google Scholar
• Percy, M., Somerville, M. J., Hicks, M., Garcia, A., Colelli, T., Wright, E., Kitaygorodsky, J., Jiang, A., Ho, V., Parpia, A. and Wong, M. K. 2014. Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke. Journal of Alzheimer’s Disease, 38, 907–922.
   PubMed Web of Science ®Google Scholar
• Percy, M. E., Somerville, M. J., Podemski, L., Wright, E., Colelli, T., Cheung, A., Leung, A., Kitaygorodsky, J. and Garcia, A. 2015. Transcobalamin 766G homozygosity, raised homocysteine, raised methylmalonic acid and high creatinine: A dementia-predisposing phenotype? Implications for dementia and Alzheimer’s disease. Austin Journal of Clinical Neurology, 2, 1062. Available at: <http://austinpublishinggroup.com/clinical-neurology/fulltext/ajcn-v2-id1062.php>
   Google Scholar
• Perluigi, M. and Butterfield, D. A. 2012. Oxidative stress and Down syndrome: a route toward Alzheimer-like dementia. Current Gerontology and Geriatrics Research, 2012, 10 pages, Article ID 724904. <http://dx.doi.org/10.1155/2012/724904>
   PubMedGoogle Scholar
• Poblador-Plou, B., Calderón-Larrañaga, A., Marta-Moreno, J., Hancco-Saavedra, J., Sicras-Mainar, A., Soljak, M. and Prados-Torres, A. 2014). Comorbidity of dementia: A cross-sectional study of primary care older patients. BMC Psychiatry, 14, 1888. doi:10.1186/1471-244X-14-84.
   Web of Science ®Google Scholar
• Pogue, A. I. and Lukiw, W. J. 2016. Aluminum, the genetic apparatus of the human CNS and Alzheimer’s disease (AD). Morphologie, 100, 56–64.10.1016/j.morpho.2016.01.001
   PubMedGoogle Scholar
• Potter, H., Granic, A. and Caneus, J. 2016. Role of trisomy 21 mosaicism in sporadic and familial Alzheimer’s disease. Current Alzheimer Research, 13, 7–17.
   PubMed Web of Science ®Google Scholar
• Prasher, V. 1994. Screening of medical problems in adults with Down syndrome. Down Syndrome Education Online. Available at: <https://www.down-syndrome.org/reports/31/>
   Google Scholar
• Prasher, V., Ninan, S. and Haque, S. 2011. Fifteen-year follow-up of thyroid status in adults with Down syndrome. Journal of Intellectual Disability Research, 56, 392–396.10.1111/jir.2011.55.issue-4
   Google Scholar
• Prasher, V. P., Janicki, M. P., Jozsvai, E., Berg, J. M., Lovering, J. S., Rashid, A. and Percy, M. Alzeimer’s disease and dementia: Implications for people with Down syndrome and other intellectual and developmental disabilities. In Wehmeyer M., Brown I., Percy M., Shogren K. editors. A comprehensive guide to intellectual and developmental disabilities. 2nd ed. Baltimore, (MD): Paul H. Brookes Publishing Co; 2017. p. 709–733.
   Google Scholar
• Prasher, V. P., Sachdeva, N. and Tarrant, N. 2015. Diagnosing dementia in adults with Down’s syndrome. Neurodegenerative Disease Management, 5, 249–256.10.2217/nmt.15.8
   PubMed Web of Science ®Google Scholar
• Prasher, V. P., Sajith, S. G., Rees, S. D., Patel, A., Tewari, S., Schupf, N. and Zigman, W. B. 2008. Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down Syndrome. International Journal of Geriatric Psychiatry, 23, 1134–1140.10.1002/gps.v23:11
   PubMed Web of Science ®Google Scholar
• Pueschel, S. M. and Werner, J. C. 1994. Mitral valve prolapse in persons with down syndrome. Research in Developmental Disabilities, 15, 91–97.10.1016/0891-4222(94)90015-9
   PubMed Web of Science ®Google Scholar
• Qiu, C., Kivipelto, M. and von Strauss, E. 2009. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues in Clinical Neuroscience, 11, 111–128.
   PubMedGoogle Scholar
• Qiu, C., Winblad, B., Marengoni, A., Klarin, I., Fastbom, J. and Fratiglioni, L. 2006. Heart failure and risk of dementia and Alzheimer disease. Archives of Internal Medicine, 166, 1003–1008.10.1001/archinte.166.9.1003
   PubMed Web of Science ®Google Scholar
• Raouf, A. A. and Tamagno, G. 2014. Encephalopathy associated with autoimmune thyroid disease. EMJ Neurology, 1, 72–77.
   Google Scholar
• Ringman, J. M., Alison Goate, A., Colin L. Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., Morris, J. C. and Dominantly Inherited Alzheimer Network. 2014. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports, 14, 499. doi:10.1007/s11910-014-0499-8.
   PubMed Web of Science ®Google Scholar
• Roizen, N. J. and Patterson, D. 2003. Down’s syndrome. The Lancet, 361, 1281–1289.10.1016/S0140-6736(03)12987-X
   PubMed Web of Science ®Google Scholar
• Rusanen, M., Kivipelto, M., Levälahti, E., Laatikainen, T., Tuomilehto, J., Soininen, H. and Ngandu, T. 2014. Heart diseases and long-term risk of dementia and Alzheimer’s disease: a population-based CAIDE study. Journal of Alzheimer’s Disease, 42, 183–191.
   PubMed Web of Science ®Google Scholar
• Sano, M., Aisen, P. S., Andrews, H. F., Tsai, W. Y., Lai, F. and Dalton, A. J., International Down syndrome and Alzheimer’s disease consortium 2016. Vitamin E in aging persons with Down syndrome. Neurology, 86, 2071–2076.10.1212/WNL.0000000000002714
   PubMed Web of Science ®Google Scholar
• Sargis, R. M. 2017. How your thyroid works. Available at: <https://www.endocrineweb.com/conditions/thyroid/how-your-thyroid-works>
   Google Scholar
• Sawin, C. T. 2002. Subclinical hyperthyroidism and atrial fibrillation. Thyroid, 12, 501–503.10.1089/105072502760143881
   PubMed Web of Science ®Google Scholar
• Scheltens, N. M., Galindo-Garre, F., Pijnenburg, Y. A., van der Vlies, A. E., Smits, L. L., Koene, T., Teunissen, C. E., Barkhof, F., Wattjes, M. P., Scheltens, P. and van der Flier, W. M. 2016. The identification of cognitive subtypes in Alzheimer’s disease dementia using latent class analysis. Journal of Neurology, Neurosurgery, & Psychiatry, 87, 235–243.10.1136/jnnp-2014-309582
   PubMed Web of Science ®Google Scholar
• Schupf, N., Lee, J. H., Wei, M., Pang, D., Chace, C., Cheng, R., Zigman, W. B., Tycko, B. and Silverman, W. 2008. Estrogen receptor-alpha variants increase risk of Alzheimer’s disease in women with Down syndrome. Dementia and Geriatric Cognitive Disorders, 25, 476–482.10.1159/000126495
   PubMed Web of Science ®Google Scholar
• Schupf, N. and Sergievsky, G. H. 2002. Genetic and host factors for dementia in Down’s syndrome. The British Journal of Psychiatry, 180, 405–410.10.1192/bjp.180.5.405
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A. and Hyman, B. T. 2015. APOEε2 is associated with milder clinical and pathological Alzheimer disease. Annals of Neurology, 77, 917–929.10.1002/ana.24369
   PubMed Web of Science ®Google Scholar
• Siew, W.-H., Tan, K.-L., Abbaspour Babaei, M., Cheah, P.-S. and Ling, K.-H. 2013. MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and fragile X syndrome. Frontiers in Cellular Neuroscience, 7, 41. doi:10.3389/fncel.2013.00041.
   PubMed Web of Science ®Google Scholar
• Silva-Tinoco, R., Carrasco Ortíz, O., Castillo-Martínez, L., Orea-Tejeda, A., Navarro Navarro, A., Reza-Albarrán, A., Keirns-Davies, C. and Tellez-Olvera, L. 2013. Persistence of thyroid hormones disorders in chronic heart failure out patients: “Heart hypothyroidism”. International Journal of Cardiology, 167, 2359–2360.10.1016/j.ijcard.2012.11.058
   PubMed Web of Science ®Google Scholar
• Silverman, R. 2014. Follow five golden rules to prevent dementia, says study. The Telegraph. Available at: <http://www.telegraph.co.uk/news/health/news/11293313/Follow-five-golden-rules-to-prevent-dementia-says-study.html>
   Google Scholar
• Smith, C. L. and Granger, C. V. 1992. Hypothyroidism producing reversible dementia. A challenge for medical rehabilitation. American Journal of Physical Medicine & Rehabilitation, 71, 28–30.10.1097/00002060-199202000-00007
   PubMed Web of Science ®Google Scholar
• Sobey, C. G., Judkins, C. P., Sundararajan, V., Phan, T. G., Drummond, G. R. and Srikanth, V. K. 2015. Risk of major cardiovascular events in people with down syndrome. PLoS One, 10, e0137093. doi:10.1371/journal.pone.0137093.
   PubMed Web of Science ®Google Scholar
• Soper, D. 2016. Calculator: Z score. Available at: <http://www.danielsoper.com/statcalc/calculator.aspx?id=22>
   Google Scholar
• Spence, J. D. 2016. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutrition Research, 36, 109–116.10.1016/j.nutres.2015.10.003
   PubMed Web of Science ®Google Scholar
• Stampfer, M. J. 2006. Cardiovascular disease and Alzheimer’s disease: common links. Journal of Internal Medicine, 260, 211–223.10.1111/jim.2006.260.issue-3
   PubMed Web of Science ®Google Scholar
• Stangroom, J. 2016. Social science statistics. Available at: <http://www.socscistatistics.com/pvalues/pearsondistribution.aspx>
   Google Scholar
• Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S. and Roses, A. D. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences, 90, 1977–1981.10.1073/pnas.90.5.1977
   PubMed Web of Science ®Google Scholar
• Struwe, F. 1929. Histopathologische Untersuchungen über Entstehung und Wesen der senilen Plaques [Histopathological studies on the origin and nature of the senile plaques]. Zeitschrift fur die gesamie Neurologie and Psychiatric, 122, 291.10.1007/BF02876635
   Google Scholar
• Sun, R., Liu, M., Lu, L., Zheng, Y. and Zhang, P. 2015. Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell Biochemistry and Biophysics, 72, 8578–8560.
   Web of Science ®Google Scholar
• Sun, X., Shan, Z. and Teng, W. 2014. Effects of increased iodine intake on thyroid disorders. Endocrinology and Metabolism, 29, 240–247.10.3803/EnM.2014.29.3.240
   Google Scholar
• Tan, Z. S., Beiser, A., Vasan, R. S., Au, R., Auerbach, S., Kiel, D. P., Wolf, P. A. and Seshadri, S. 2008. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Archives of Internal Medicine, 168, 1514–1520.10.1001/archinte.168.14.1514
   PubMedGoogle Scholar
• Tan, Z. S. and Vasan, R. S. 2009. Thyroid function and Alzheimer’s disease. Journal of Alzheimer’s Disease, 16, 503–507.
   PubMed Web of Science ®Google Scholar
• Temple, V., Jozsvai, E., Konstantareas, M. M. and Hewitt, T. A. 2001. Alzheimer dementia in Down’s syndrome: the relevance of cognitive ability. Journal of Intellectual Disability Research, 45, 47–55.10.1046/j.1365-2788.2001.00299.x
   PubMed Web of Science ®Google Scholar
• Triggiani, V., Angelo Giagulli, V., De Pergola, G., Licchelli, B., Guastamacchia, E. and Iacoviello, M. 2016. Mechanisms explaining the influence of subclinical hypothyroidism on the onset and progression of chronic heart failure. Endocrine Metabolic & Immune Disorders — Drug Targets, 16, 2–7.10.2174/1871530316666151218151319
   PubMed Web of Science ®Google Scholar
• Troncone, L., Luciani, M., Coggins, M., Wilker, E. H., Ho, C. Y., Codispoti, K. E., Frosch, M. P., Kayed, R. and Del Monte, F. 2016. Aβ amyloid pathology affects the hearts of patients with Alzheimer’s disease. Journal of the American College of Cardiology, 68, 2395–2407.10.1016/j.jacc.2016.08.073
   PubMed Web of Science ®Google Scholar
• Tyrrell, J., Cosgrave, M., Hawi, Z., McPherson, J., O’Brien, C., McCalvert, J., McLaughlin, M., Lawlor, B. and Gill, M. 1998. A protective effect of apolipoprotein E e2 allele on dementia in Down’s syndrome. Biological Psychiatry, 43, 397–400.10.1016/S0006-3223(97)00481-2
   PubMed Web of Science ®Google Scholar
• Vetrano, D. L., Carfì, A., Brandi, V., L’Angiocola, P. D., Di Tella, S., Cipriani, M. C., Antocicco, M., Zuccalà, G., Palmieri, V., Silveri, M. C., Bernabei, R. and Onder, G. 2016. Left ventricle diastolic function and cognitive performance in adults with Down syndrome. International Journal of Cardiology, 203, 816–818. doi:10.1016/j.ijcard.2015.11.041.
   PubMed Web of Science ®Google Scholar
• Vis, J. C., Duffels, M. G., Winter, M. M., Weijerman, M. E., Cobben, J. M., Huisman, S. A. and Mulder, B. J. 2009. Down syndrome: a cardiovascular perspective. Journal of Intellectual Disability Research, 53, 419–425.10.1111/jir.2009.53.issue-5
   PubMed Web of Science ®Google Scholar
• Vis, J. C., de Bruin-Bon, R. H., Bouma, B. J., Backx, A. P., Huisman, S. A., Imschoot, L. and Mulder, B. J. 2012. ‘The sedentary heart’: physical inactivity is associated with cardiac atrophy in adults with an intellectual disability. International Journal of Cardiology, 158, 387–393.10.1016/j.ijcard.2011.01.064
   PubMed Web of Science ®Google Scholar
• von Strauss, E., Viitanen, M., De Ronchi, D., Winblad, B. and Fratiglioni, L. 1999. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Archives of Neurology, 56, 587–592.10.1001/archneur.56.5.587
   PubMedGoogle Scholar
• Wallace, R. A. and Dalton, A. J. 2006. Clinicians’ guide to physical health problems of older adults with Down syndrome. Journal on Developmental Disabilities, 12, 1–92.
   Google Scholar
• Wilcock, D. M., Schmitt, F. A. and Head, E. 2015. Cerebrovascular contributions to aging and Alzheimer’s disease in Down syndrome. Biochimica et Biophysica Acta, 1862, 909–914.
   PubMed Web of Science ®Google Scholar
• Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L., Fisher, E. M. and Strydom, A. 2015. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nature Reviews Neuroscience, 16, 564–574.10.1038/nrn3983
   PubMed Web of Science ®Google Scholar
• Wood, W. G., Li,L, Müller, W. E. and Eckert, G. P. (2014). Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. Journal of Neurochemistry, 129, 559–572.10.1111/jnc.2014.129.issue-4
   PubMed Web of Science ®Google Scholar
• Yaffe, K. and Hoang, T. 2013. Nonpharmacologic treatment and prevention strategies for dementia. Continuum (Minneapolis, Minn.), 9, 372–381.
   Google Scholar
• Ylä-Herttuala, S., Luoma, J., Nikkari, T. and Kivimäki, T. 1989. Down’s syndrome and atherosclerosis. Atherosclerosis, 76, 269–272.10.1016/0021-9150(89)90110-X
   PubMed Web of Science ®Google Scholar
• Yong-Hong, L., Xiao-Dong, P., Chang-Quan, H., Bo, Y. and Qing-Xiu, L. 2013. Hypothalamic-pituitary-thyroid axis in patients with Alzheimer Disease (AD). Journal of Investigative Medicine, 61, 578–581.10.2310/JIM.0b013e318280aafb
   PubMed Web of Science ®Google Scholar
• Zhao, Q., Lee, J. H., Pang, D., Temkin, A., Park, N., Janicki, S. C., Zigman, W. B., Silverman, W., Tycko, B. and Schupf, N. 2011. Estrogen receptor-beta variants are associated with increased risk of Alzheimer’s disease in women with Down syndrome. Dementia and Geriatric Cognitive Disorders, 32, 241–249.10.1159/000334522
   PubMed Web of Science ®Google Scholar
• Zhao, Y. and Lukiw, W. J. 2015. Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease (AD). Journal of Natural Sciences. 1–5. pii: e138. Available at: <http://www.jnsci.org/files/article/e138.pdf>
   Google Scholar